login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

Endologix’s IntuiTrak demonstrated at the International Congress in Arizona


Thursday, 12 Feb 2009 12:14

A live-case demonstration of the Endologix’s new IntuiTrak Delivery System was featured at the International Congress XXII Endovascular Interventions conference in Scottsdale, US.


The procedure was performed by Dr Zvonimir Krajcer, Texas Heart Institute; Dr Edward Diethrich, Arizona Heart Institute; and Dr Venkatesh G Ramaiah, Arizona Heart Hospital. The endovascular abdominal aortic aneurysm procedure was successfully performed with a percutaneous approach and local anesthesia.

IntuiTrak is a system developed for the minimally invasive delivery and deployment of the Powerlink stent graft. The device is currently in limited market release following FDA approval in October 2008. IntuiTrak’s novel design and deployment mechanism simplifies standard vascular delivery of the Powerlink and provides accuracy and control. According to Endologix, the low-profile delivery system features enhanced flexibility, advanced hemostasis control and a hydrophilic coating to facilitate smooth delivery, particularly in patients with limited or difficult vascular access. Additionally, the delivery catheter has an integrated sheath that minimises the need to exchange introducers, thereby having the potential to minimize vessel trauma and reduce overall procedure time.


"Due to its low-profile and integrated sheath, IntuiTrak is ideal for the percutaneous treatment of patients with AAA," said Krajcer. "I have used the new device in eight cases so far, and have experienced 100% technical success and exceptional patient outcomes."





Add New Comment

Most popular


DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients
Friday, 29 Aug 2014
The multicentre, 800-patient study also demonstrated that directional atherectomy was non-inferior for treating peripheral arterial disease in patients with diabetes compared with those without ... DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients

Similar results with elective post-EVAR open conversion and primary open juxtarenal aneurysm repair for type Ia endoleak
Wednesday, 13 Aug 2014
Elective open surgical conversion for type Ia endoleak after endovascular aneurysm repair (EVAR) is not associated with increased morbidity or mortality compared with open juxtarenal aneurysm repair ... Similar results with elective post-EVAR open conversion and primary open juxtarenal aneurysm repair for type Ia endoleak

High patency rates with early cannulation graft with bioactive surface
Friday, 15 Aug 2014
Results of vascular access using a new ePTFE graft show “satisfactory” primary patency rates at one year, and are similar to those achieved with an autogenous access. In the experience, conducted in ... High patency rates with early cannulation graft with bioactive surface

Features


“Only operators and centres with the highest skill sets should be performing complex TEVAR”
Monday, 22 Sep 2014
With advances in technology, device availability and surgical skill sets we can expect the outcomes from endovascular repair of thoracoabdominal aortic aneurysms to continue to improve and become the ... “Only operators and centres with the highest skill sets should be performing complex TEVAR”

Eversion carotid endarterectomy: A technique that matters
Wednesday, 10 Sep 2014
Philip S K Paty, Albany, USA, says that eversion carotid endarterectomy is the preferred technique to treat carotid artery disease. Over the past two decades, his centre has performed over 11,000 of ... Eversion carotid endarterectomy: A technique that matters

Profiles


Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Andrew Holden
Tuesday, 11 Feb 2014
Andrew Holden has been involved in the investigation of several endovascular devices for the ... Andrew Holden

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions